Mouse models of chemically-induced lung carcinogenesis

Frontiers in Bioscience - Elite

Volumn 5 E, Issue 3, 2013, Pages 939-946

  Vikis, Haris G ^a   Rymaszewski, Amy L ^a   Tichelaar, Jay W ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

A J strain; Adenoma; Carcinogen; Chemoprevention; Review

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ANTINEOPLASTIC AGENT; BENZO[A]PYRENE; CARBAMIC ACID; CIGARETTE SMOKE; EPIGALLOCATECHIN GALLATE; K RAS PROTEIN; NUTRACEUTICAL; PROTEIN P53; RETINOBLASTOMA PROTEIN; URETHAN; VINYL DERIVATIVE;

A J MOUSE; ARTICLE; C57BL 6 MOUSE; CANCER GROWTH; CANCER MODEL; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CHEMOPROPHYLAXIS; CODON; DBA MOUSE; DRUG SCREENING; GENE MUTATION; GENETIC MANIPULATION; HUMAN; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG SQUAMOUS CELL CARCINOMA; MOUSE MODEL; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRECANCER; RODENT MODEL; STRAIN DIFFERENCE; SWISS WEBSTER MOUSE;

MURINAE;

EID: 84884318689     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e673     Document Type: Article

References (60)

1. A. Jemal, R. Siegel, J. Xu and E. Ward: Cancer statistics, 2010. CA: a cancer journal for clinicians, 60(5), 277-300 (2010)
2. D. A. Tuveson and T. Jacks: Modeling human lung cancer in mice: similarities and shortcomings. Oncogene, 18(38), 5318-24 (1999)
3. R. Meuwissen and A. Berns: Mouse models for human lung cancer. Genes & development, 19(6), 643-64 (2005)
4. S. de Seranno and R. Meuwissen: Progress and applications of mouse models for human lung cancer. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology, 35(2), 426-43 (2010)
5. M. B. Shimkin and G. D. Stoner: Lung tumors in mice: application to carcinogenesis bioassay. Advances in cancer research, 21, 1-58 (1975)
6. S. S. Hecht: Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nature reviews. Cancer, 3(10), 733-44 (2003)
7. A. M. Malkinson: The genetic basis of susceptibility to lung tumors in mice. Toxicology, 54(3), 241-71 (1989)
8. A. M. Malkinson: Primary lung tumors in mice: an experimentally manipulable model of human adenocarcinoma. Cancer Research, 52(9 Suppl), 2670s-2676s (1992)
9. S. Anttila, H. Raunio and J. Hakkola: Cytochrome P450-mediated pulmonary metabolism of carcinogens: regulation and cross-Talk in lung carcinogenesis. American journal of respiratory cell and molecular biology, 44(5), 583-90 (2011)
10. S. S. Hecht: DNA adduct formation from tobaccospecific N-nitrosamines. Mutation research, 424(1-2), 127-42 (1999)
11. Y. Weng, C. Fang, R. J. Turesky, M. Behr, L. S. Kaminsky and X. Ding: Determination of the role of target tissue metabolism in lung carcinogenesis using conditional cytochrome P450 reductase-null mice. Cancer Research, 67(16), 7825-32 (2007)
12. G. Manenti and T. A. Dragani: Pas1 haplotypedependent genetic predisposition to lung tumorigenesis in rodents: a meta-Analysis. Carcinogenesis, 26(5), 875-82 (2005)
13. G. P. Pfeifer, M. F. Denissenko, M. Olivier, N. Tretyakova, S. S. Hecht and P. Hainaut: Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-Associated cancers. Oncogene, 21(48), 7435-51 (2002)
14. A. M. Malkinson and D. S. Beer: Major effect on susceptibility to urethan-induced pulmonary adenoma by a single gene in BALB/cBy mice. Journal of the National Cancer Institute, 70(5), 931-6 (1983)
15. N. Wakamatsu, T. R. Devereux, H. H. Hong and R. C. Sills: Overview of the molecular carcinogenesis of mouse lung tumor models of human lung cancer. Toxicologic pathology, 35(1), 75-80 (2007)
16. P. Demant: Cancer susceptibility in the mouse: genetics, biology and implications for human cancer. Nature reviews. Genetics, 4(9), 721-34 (2003)
17. P. Liu, Y. Wang, H. Vikis, A. Maciag, D. Wang, Y. Lu, Y. Liu and M. You: Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice. Nature genetics, 38(8), 888-95 (2006)
18. A. M. Malkinson: Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung. Lung cancer, 32(3), 265-79 (2001)
19. V. E. Steele and R. A. Lubet: The use of animal models for cancer chemoprevention drug development. Seminars in oncology, 37(4), 327-38 (2010)
20. S. S. Hecht, S. Isaacs and N. Trushin: Lung tumor induction in A/J mice by the tobacco smoke carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene: a potentially useful model for evaluation of chemopreventive agents. Carcinogenesis, 15(12), 2721-5 (1994)
21. M. You, U. Candrian, R. R. Maronpot, G. D. Stoner and M. W. Anderson: Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proceedings of the National Academy of Sciences of the United States of America, 86(9), 3070-4 (1989)
22. S. S. Hecht, M. A. Morse, S. Amin, G. D. Stoner, K. G. Jordan, C. I. Choi and F. L. Chung: Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the effect of diet. Carcinogenesis, 10(10), 1901-4 (1989)
23. S. A. Belinsky, T. R. Devereux, J. F. Foley, R. R. Maronpot and M. W. Anderson: Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. Cancer Res, 52(11), 3164-73 (1992)
24. Y. Horio, A. Chen, P. Rice, J. A. Roth, A. M. Malkinson and D. S. Schrump: Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice. Mol Carcinog, 17(4), 217-23 (1996)
25. E. O. Nuzum, A. M. Malkinson and D. G. Beer: Specific Ki-ras codon 61 mutations may determine the development of urethan-induced mouse lung adenomas or adenocarcinomas. Mol Carcinog, 3(5), 287-95 (1990)
26. T. Ichikawa, Y. Yano, M. Uchida, S. Otani, K. Hagiwara and T. Yano: The activation of K-ras gene at an early stage of lung tumorigenesis in mice. Cancer Lett, 107(2), 165-70 (1996)
27. W. T. Gunning, P. M. Kramer, R. A. Lubet, V. E. Steele and M. A. Pereira: Chemoprevention of vinyl carbamate-induced lung tumors in strain A mice. Exp Lung Res, 26(8), 757-72 (2000)
28. J. F. Foley, M. W. Anderson, G. D. Stoner, B. W. Gaul, J. F. Hardisty and R. R. Maronpot: Proliferative lesions of the mouse lung: progression studies in strain A mice. Exp Lung Res, 17(2), 157-68 (1991)
29. R. Balansky, G. Ganchev, M. Iltcheva, V. E. Steele, F. D'Agostini and S. De Flora: Potent carcinogenicity of cigarette smoke in mice exposed early in life. Carcinogenesis, 28(10), 2236-43 (2007)
30. H. Witschi: A/J mouse as a model for lung tumorigenesis caused by tobacco smoke: strengths and weaknesses. Experimental lung research, 31(1), 3-18 (2005)
31. J. A. Hutt, B. R. Vuillemenot, E. B. Barr, M. J. Grimes, F. F. Hahn, C. H. Hobbs, T. H. March, A. P. Gigliotti, S. K. Seilkop, G. L. Finch, J. L. Mauderly and S. A. Belinsky: Lifespan inhalation exposure to mainstream cigarette smoke induces lung cancer in B6C3F1 mice through genetic and epigenetic pathways. Carcinogenesis, 26(11), 1999-2009 (2005)
32. S. S. Hecht, C. B. Chen, T. Ohmori and D. Hoffmann: Comparative carcinogenicity in F344 rats of the tobaccospecific nitrosamines, N'-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res, 40(2), 298-302 (1980)
33. J. L. Mauderly, A. P. Gigliotti, E. B. Barr, W. E. Bechtold, S. A. Belinsky, F. F. Hahn, C. A. Hobbs, T. H. March, S. K. Seilkop and G. L. Finch: Chronic inhalation exposure to mainstream cigarette smoke increases lung and nasal tumor incidence in rats. Toxicological sciences : an official journal of the Society of Toxicology, 81(2), 280-92 (2004)
34. Y. Wang, Z. Zhang, Y. Yan, W. J. Lemon, M. LaRegina, C. Morrison, R. Lubet and M. You: A chemically induced model for squamous cell carcinoma of the lung in mice: histopathology and strain susceptibility. Cancer Research, 64(5), 1647-54 (2004)
35. J. D. Minna: The molecular biology of lung cancer pathogenesis. Chest, 103(4 Suppl), 449S-456S (1993)
36. M. You and G. Bergman: Preclinical and clinical models of lung cancer chemoprevention. Hematology/oncology clinics of North America, 12(5), 1037-53 (1998)
37. C. A. Cooper, F. A. Carby, V. J. Bubb, D. Lamb, K. M. Kerr and A. H. Wyllie: The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lung. The Journal of pathology, 181(4), 401-4 (1997)
38. S. Rodenhuis and R. J. Slebos: Clinical significance of ras oncogene activation in human lung cancer. Cancer Research, 52(9 Suppl), 2665s-2669s (1992)
39. S. Rodenhuis, R. J. Slebos, A. J. Boot, S. G. Evers, W. J. Mooi, S. S. Wagenaar, P. C. van Bodegom and J. L. Bos: Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Research, 48(20), 5738-41 (1988)
40. L. Ding, G. Getz, D. A. Wheeler, E. R. Mardis, M. D. McLellan, K. Cibulskis, C. Sougnez, H. Greulich, D. M. Muzny, M. B. Morgan, L. Fulton, R. S. Fulton, Q. Zhang, M. C. Wendl, M. S. Lawrence, D. E. Larson, K. Chen, D. J. Dooling, A. Sabo, A. C. Hawes, H. Shen, S. N. Jhangiani, L. R. Lewis, O. Hall, Y. Zhu, T. Mathew, Y. Ren, J. Yao, S. E. Scherer, K. Clerc, G. A. Metcalf, B. Ng, A. Milosavljevic, M. L. Gonzalez-Garay, J. R. Osborne, R. Meyer, X. Shi, Y. Tang, D. C. Koboldt, L. Lin, R. Abbott, T. L. Miner, C. Pohl, G. Fewell, C. Haipek, H. Schmidt, B. H. Dunford-Shore, A. Kraja, S. D. Crosby, C. S. Sawyer, T. Vickery, S. Sander, J. Robinson, W. Winckler, J. Baldwin, L. R. Chirieac, A. Dutt, T. Fennell, M. Hanna, B. E. Johnson, R. C. Onofrio, R. K. Thomas, G. Tonon, B. A. Weir, X. Zhao, L. Ziaugra, M. C. Zody, T. Giordano, M. B. Orringer, J. A. Roth, M. R. Spitz, Wistuba, II, B. Ozenberger, P. J. Good, A. C. Chang, D. G. Beer, M. A. Watson, M. Ladanyi, S. Broderick, A. Yoshizawa, W. D. Travis, W. Pao, M. A. Province, G. M. Weinstock, H. E. Varmus, S. B. Gabriel, E. S. Lander, R. A. Gibbs, M. Meyerson and R. K. Wilson: Somatic mutations affect key pathways in lung adenocarcinoma. Nature, 455(7216), 1069-75 (2008)
41. A. M. Malkinson: Molecular comparison of human and mouse pulmonary adenocarcinomas. Experimental lung research, 24(4), 541-55 (1998)
42. W. Duan, L. Gao, X. Wu, E. M. Hade, J. X. Gao, H. Ding, S. H. Barsky, G. A. Otterson and M. A. Villalona-Calero: Expression of a mutant p53 results in an age-related demographic shift in spontaneous lung tumor formation in transgenic mice. PLoS ONE, 4(5), e5563 (2009)
43. U. Mohr, Reznik, G.: Tobacco Carcinogenesis. Pathogenesis and Therapy of Lung Cancer (C. C. Harris, Ed.), 263-368 (1978)
44. T. Gordon and M. Bosland: Strain-dependent differences in susceptibility to lung cancer in inbred mice exposed to mainstream cigarette smoke. Cancer letters, 275(2), 213-20 (2009)
45. T. Yoshimoto, F. Hirao, M. Sakatani, H. Nishikawa and T. Ogura: Induction of squamous cell carcinoma in the lung of C57BL/6 mice by intratracheal instillation of benzo[a]pyrene with charcoal powder. Gann = Gan, 68(3), 343-52 (1977)
46. T. Yoshimoto, T. Inoue, H. Iizuka, H. Nishikawa, M. Sakatani, T. Ogura, F. Hirao and Y. Yamamura: Differential induction of squamous cell carcinomas and adenocarcinomas in mouse lung by intratracheal instillation of benzo(a)pyrene and charcoal powder. Cancer Research, 40(11), 4301-7 (1980)
47. C. J. Henry, L. H. Billups, M. D. Avery, T. H. Rude, D. R. Dansie, A. Lopez, B. Sass, C. E. Whitmire and R. E. Kouri: Lung cancer model system using 3-methylcholanthrene in inbred strains of mice. Cancer Research, 41(12 Pt 1), 5027-32 (1981)
48. W. Lijinsky and M. D. Reuber: Neoplasms of the skin and other organs observed in Swiss mice treated with nitrosoalkylureas. Journal of cancer research and clinical oncology, 114(3), 245-9 (1988)
49. T. M. Hudish, L. I. Opincariu, A. B. Mozer, M. S. Johnson, T. G. Cleaver, S. P. Malkoski, D. Merrick and R. L. Keith: N-nitroso-Tris-chloroethylurea induces premalignant squamous dysplasia in mice. Cancer Prev Res (Phila) (2011)
50. A. K. Bauer, A. M. Malkinson and S. R. Kleeberger: Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities. American journal of physiology. Lung cellular and molecular physiology, 287(4), L685-703 (2004)
51. S. Leone-Kabler, L. L. Wessner, M. F. McEntee, R. B. D'Agostino, Jr. and M. S. Miller: Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors. Carcinogenesis, 18(6), 1163-8 (1997)
52. A. M. Malkinson: Role of inflammation in mouse lung tumorigenesis: a review. Experimental lung research, 31(1), 57-82 (2005)
53. A. K. Bauer, L. D. Dwyer-Nield, J. A. Hankin, R. C. Murphy and A. M. Malkinson: The lung tumor promoter, butylated hydroxytoluene (BHT), causes chronic inflammation in promotion-sensitive BALB/cByJ mice but not in promotion-resistant CXB4 mice. Toxicology, 169(1), 1-15 (2001)
54. A. K. Bauer, L. D. Dwyer-Nield, K. Keil, K. Koski and A. M. Malkinson: Butylated hydroxytoluene (BHT) induction of pulmonary inflammation: a role in tumor promotion. Exp Lung Res, 27(3), 197-216 (2001)
55. A. M. Malkinson, K. M. Koski, W. A. Evans and M. F. Festing: Butylated hydroxytoluene exposure is necessary to induce lung tumors in BALB mice treated with 3-methylcholanthrene. Cancer Res, 57(14), 2832-4 (1997)
56. A. K. Bauer, A. M. Malkinson and S. R. Kleeberger: Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities. Am J Physiol Lung Cell Mol Physiol, 287(4), L685-703 (2004)
57. H. G. Vikis, A. E. Gelman, A. Franklin, L. Stein, A. Rymaszewski, J. Zhu, P. Liu, J. W. Tichelaar, A. S. Krupnick and M. You: Neutrophils are required for 3-methylcholanthrene-initiated, butylated hydroxytoluenepromoted lung carcinogenesis. Molecular carcinogenesis (2011)
58. E. A. Rondini, D. M. Walters and A. K. Bauer: Vanadium pentoxide induces pulmonary inflammation and tumor promotion in a strain-dependent manner. Part Fibre Toxicol, 7, 9 (2010)
59. A. Bellocq, M. Antoine, A. Flahault, C. Philippe, B. Crestani, J. F. Bernaudin, C. Mayaud, B. Milleron, L. Baud and J. Cadranel: Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. Am J Pathol, 152(1), 83-92 (1998)
60. Q. Zhang, H. Fu, J. Pan, J. He, S. Ryota, Y. Hara, Y. Wang, R. A. Lubet and M. You: Effect of dietary Polyphenon E and EGCG on lung tumorigenesis in A/J Mice. Pharm Res, 27(6), 1066-71 (2010)